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Crystal structure of porcine cathepsin H determined at 2.1 Å
resolution: location of the mini-chain C-terminal carboxyl 
group defines cathepsin H aminopeptidase function
Gregor Guncar*, Marjetka Podobnik, Joze Pungercar, Borut Štrukelj, Vito Turk
and Dušan Turk
Background: Cathepsin H is a lysosomal cysteine protease, involved in
intracellular protein degradation. It is the only known mono-aminopeptidase in
the papain-like family and is reported to be involved in tumor metastasis. The
cathepsin H structure was determined in order to investigate the structural basis
for its aminopeptidase activity and thus to provide the basis for structure-based
design of synthetic inhibitors.
Results: The crystal structure of native porcine cathepsin H was determined at
2.1 Å resolution. The structure has the typical papain-family fold. The so-called
mini-chain, the octapeptide EPQNCSAT, is attached via a disulfide bond to the
body of the enzyme and bound in a narrowed active-site cleft, in the substrate-
binding direction. The mini-chain fills the region that in related enzymes
comprises the non-primed substrate-binding sites from S2 backwards. 
Conclusions: The crystal structure of cathepsin H reveals that the mini-chain
has a definitive role in substrate recognition and that carbohydrate residues
attached to the body of the enzyme are involved in positioning the mini-chain in
the active-site cleft. Modeling of a substrate into the active-site cleft suggests
that the negatively charged carboxyl group of the C terminus of the mini-chain
acts as an anchor for the positively charged N-terminal amino group of a
substrate. The observed displacements of the residues within the active-site
cleft from their equivalent positions in the papain-like endopeptidases suggest
that they form the structural basis for the positioning of both the mini-chain and
the substrate, resulting in exopeptidase activity.
Introduction
Cathepsin H (EC 3.4.22.16) is a relatively abundant pro-
tease and, like other lysosomal cysteine proteases, is
involved in intracellular protein degradation [1]. There is a
growing body of evidence that the level of cathepsin H or
cathepsin H-like enzymes [2] is increased in disease states,
including breast carcinoma [3], melanoma and tumor meta-
stasis [4]. In the condition mucolipidosis II [5], cathepsin
H activity is diminished, together with that of other
cathepsins. Cysteine proteases are no longer seen as lyso-
somal enzymes only, but are involved in numerous
processes outside the lysosome [6]. For example, a cathep-
sin H-like enzyme has been found in cells from a human
melanoma cell line [2]. This enzyme can degrade fibrino-
gen and fibronectin and thus may, together with other
proteases, be involved in the destruction of extracellular
matrix components, leading to cancer proliferation, migra-
tion and metastasis [2]. 
Mature cathepsin H consists of three fragments, the N-
terminal heavy and C-terminal light chains, and an
octapeptide called the mini-chain [7]. Cleavage of the
enzyme between the heavy and light chains is partial and
can occur between residues Asn168B and Gly168C (papain
numbering). The ratio of cleaved to uncleaved forms
varies between different species and organs, but in general
the two-chain form is present in larger amounts than the
three-chain form [7–9].
The amino-acid sequences of rat [8], human [10] and
mouse cathepsin H [11] are in agreement with those
derived from the rat [12] and human [13] cDNA sequences.
From these sequences, it is evident that the mini-chain
originates from the cathepsin H propeptide and that it is
located between propeptide residues Glu76P and Thr83P
(propeptide numbering). Sequence homology shows that
cathepsin H belongs to the superfamily of papain-like cys-
teine proteases, which includes the mammalian lysosomal
cathepsins B, L, S, K and N [14] and the plant enzymes
papain, actinidin, aleurain and oryzains. The closest plant
enzymes are aleurain [15] and oryzain γ [16].
Cathepsin H is inhibited by the three groups of intracellu-
lar and extracellular protein inhibitors — stefins [17–19],
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cystatins [20] and kininogens [7]. Cathepsin H interacts
with these inhibitors more strongly than does cathepsin B
but less strongly than do the endopeptidases papain and
cathepsin L. An exception is stefin B, which is a stronger
inhibitor of cathepsin H than of the endopeptidases [17,19].
In contrast to cathepsins B, L [21], S [22] and K [23],
cathepsin H is only slowly inhibited by irreversible epoxy-
succinyl-based inhibitors derived from E-64 [21]. It is not
inhibited by leupeptin [24]. It is, however, strongly inhib-
ited by substrate analogues composed of a single amino-
acid residue bound to a diazomethane or fluoromethane
group, which react with the active-site cysteine [25].
Cathepsins H, B and C are the only known papain-like
lysosomal cysteine exopeptidases [14]. Cathepsin H is
an aminopeptidase [26,27], cleaving a single N-terminal
residue from a polypeptide chain, while cathepsin C is an
aminodipeptidase [28] and cathepsin B is a carboxydipep-
tidase [29]. It has been reported that cathepsin H also
exhibits endopeptidase activity [30]. The active-site cleft
of papain and the related endopeptidases, cathepsins K
[31,32] and L [33], is empty, whereas the occluding loop
of cathepsin B [34] occupies the back of the active-site
cleft, thus making cathepsin B a carboxydipeptidase.
Using chemical and enzymatic cleavage methods, it has
previously been shown that the mini-chain is bound via a
disulfide bond to Cys205 of the body of cathepsin H [35].
It was proposed [35] that the mini-chain is involved in the
steric regulation of the accessibility of the active-site cleft.
The way in which the mini-chain specifies the aminopep-
tidase activity is shown in detail in the structure of cathep-
sin H presented here.
Results
Papain numbering of residues is used throughout this
paper. The insertions of cathepsin H residues are denoted
by appending a letter to the sequence number preceding
each insertion, starting with ‘A’. The mini-chain residues
are numbered as they occur in pro-cathepsin H, as deduced
from the cDNA sequence, with the letter ‘P’ added.
Overall structure
The cathepsin H molecule is well defined by the electron-
density map, the only exceptions being the N-terminal
residue, Tyr1, the N-terminal residue of the mini-chain
Glu76P and a few sidechains. The structure confirms the
pattern of the disulfide bridges in bovine cathepsin H [35],
including that formed between Cys205 and the mini-
chain Cys80P. The three disulfide bridges Cys22–Cys63,
Cys56–Cys95 and Cys154–Cys200 are topologically equiva-
lent to the disulfide bridges in actinidin [36]. Cathepsin H
is an ellipsoidal molecule with dimensions 32 × 26.5 × 24 Å
(calculated using GRASP [37]). Its fold is typical of a papain
[38] superfamily member. The structure consists of right
(R-) and left (L-) domains, forming the body of the enzyme,
as shown in the standard view (Figure 1), with the addition
of an octapeptide bound to the R-domain.
The predominant secondary structure of the L-domain is
α helix, whereas the scaffold of the R-domain is based on
a β barrel. The two domains interact through an extended
amphipathic interface stabilized by numerous hydrogen
bonds as well as by hydrophobic contacts. The two-domain
interface opens at the top into a V-shaped active-site cleft
in which the two catalytic residues, Cys25 and His159, and
the mini-chain are located. 
Superposition of the Cα atoms of cathepsin H on the Cα
atoms of papain, actinidin and cathepsin B shows that
180 amino-acid residues of cathepsin H and actinidin
[36] are topologically equivalent, 173 with papain [39]
and 156 with human cathepsin B [34], yielding root mean
square (rms) deviations of 0.85 Å, 0.85 Å and 0.83 Å,
respectively. Structure-based alignment of those enzymes
is presented in Figure 2. The numbers of equivalently
positioned residues indicate that cathepsin H is struc-
turally most similar to actinidin. The differences between
the two structures are mostly insertions and deletions in
the loop regions. 
Mature porcine cathepsin H has two N-glycosylation sites,
Asn112 on the body of the enzyme and Asn79P on the
mini-chain [40]. Carbohydrate residues are frequently not
visible in a crystal structure. In cathepsin H, only the first
three carbohydrate rings attached to Asn112 and located in
the front region of the active site are clearly visible in the
electron-density maps. This is the result of these carbohy-
drate rings and the mini-chain being closely packed in the
active-site cleft (Figure 3). The Asn79P sidechain is glyco-
sylated, but the observed electron-density map extending
from its sidechain is not clear enough to allow us to recog-
nize sugar rings.
The active-site cleft
The active-site cleft of a papain-like cysteine protease
runs across the top of the molecule. The cleft has broad
ends but narrows in the middle, where the catalytic
residues Cys25, His159 and Gln19 reside. In the cathepsin
H structure, the front part of the cleft is filled with carbo-
hydrate residues on the left and mini-chain in the middle,
whereas the back part is unoccupied and thus free for sub-
strate binding (Figure 3).
The backbone and sidechains of the catalytic residues are
found at the positions usual for a papain-like enzyme. The
only exception is the His159 imidazole ring which in, con-
trast to all other known structures of cysteine proteases,
does not form a thiolate–imidazolium ion pair with Cys25.
The His159 is instead rotated 80° about the Cα–Cβ bond
and its Nε proton is involved in a salt bridge with the
C-terminal carboxyl group of Val212A from a neighboring
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molecule in the crystal (Figure 4). Its Nδ hydrogen atom
stabilizes the orientation of the ring on the other side by
forming a hydrogen bond with Oδ1 from the preceding
residue, Asn158. Two well-defined solvent molecules
occupy the cavity behind the His159 imidazole ring, where
this residue would normally have been expected to be
found. We account for this unusual positioning of the histi-
dine imidazole ring by crystal packing. It is evident,
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Figure 2
cath YPPSMDWRKKG--NF--VS-PVKNQGSCGSCWTFSTTGALESAVAIATG-KMLSLAEQQLVDCAQNFN--NH
9pap IPEYVDWRQ-K--GA--VT-PVKNQGSCGSCWAFSAVVTIEGIIKIRTG-NLNQYSEQELLDCDR--R--SY
2act LPSYVDWRS-A--GA--VV-DIKSQGECGGCWAFSAIATVEGINKITSG-SLISLSEQELIDCGRT-QN-TR
1huc LPASFDAREQWPQC-PTI-KEIRDQGSCGSCWAFGAVEAISDRICIHT-NVSVEVSAEDLLTCCGSM--CGD
cath GCQGGLPSQAFEYIRYNKGIMGE-------DTYPYKGQ-------------------D-D-HCK-F---QP-
9pap GCNGGYPWSALQLVAQY-GIHYR-------NTYPYEGV-------------------Q-R-YCR-SREK---
2act GCDGGYITDGFQFIINDGGINTE-------ENYPYTAQ-------------------D-G-DCDV--ALQD-
1huc GCNGGYPAEAWNFWTRK-GLVSGGLYESHVGCRPYSI-PPCEHHVNGSRPPCTGEGDTP-K-CSK---I---
cath ---------DK--AIAFVKDVANITMNDEEAMVEAVALYNPVSFAFEV-TNDFLMYRKGIYSST-SCHKTPD
9pap --------GP---YAAKTDGVRQVQPYNQGALLYSIA-NQPVSVVLQAAGKDFQLYRGGIFVG-PCGN----
2act ----------Q--KYVTIDTYENVPYNNEWALQTAVT-YQPVSVALDAAGDAFKQYASGIFTG-PCGT----
1huc CEPGYSPTYK-QDK-HYGYNSYSVSN-SEKDIMAEIYKNGPVEGAFSV-YSDFLLYKSGVYQ--H-------
cath -------KVNHAVLAVGYGEENGIPYWIVKNSWGPQWGMNGYFLIERG--K--NMCGLAACASYPIPL-V--
9pap -------KVDHAVAAVGYGP----NYILIKNSWGTGWGENGYIRIKRGTGNSYGVCGLYTSSFYPVK-N---
2act -------AVDHAIVIVGYGTEGGVDYWIVKNSWDTTWGEEGYMRILRNV-GGAGTCGIATMPSYPVK-Y---
1huc VTGEMMG--GHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRG--Q--DHCGIESEVVAGIPR--TD
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Structure-based alignment of the sequences of cathepsin H (cath) with papain (9pap [39]), actinidin (2act [36]) and cathepsin B (1huc [34]).
Identical residues are shaded in black, similar residues in gray. 
Figure 1
The overall structure of cathepsin H. 
(a) Ribbon diagram of the body of cathepsin
H (blue ribbons) in the standard view with
stick representations of the catalytic residue
Cys25 (white) at the top of the central helix,
the mini-chain in the active-site cleft (orange)
and the carbohydrate moiety connected to
Asn112 (red). The nitrogen, oxygen and sulfur
atom sticks in the mini-chain and Cys25 are
colored blue, red and yellow, respectively. The
figure was prepared using the program
RIBBONS [66]. (b) Stereo picture of the Cα
trace of cathepsin H (thick lines) in standard
orientation, superimposed with actinidin (thin
lines). Marked residues are those of cathepsin
H. Only the disulfide bridge between the mini-
chain and the body of cathepsin H is shown.
The figure was produced using the program
MAIN [61].
(a)
(b)
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however, that the catalytic histidine sidechain is capable of
adopting various conformations within the active-site cleft.
The mini-chain and the Asn112-bound carbohydrate region
The mini-chain runs in an extended conformation in the
substrate-binding direction along the front side of the
active-site cleft (Figures 3 and 5). The residues Pro77P
to Cys80P are in an extended β-strand conformation.
Ser81P and Ala82P continue the β-strand-like orientation
of peptide bonds, but the chain forms a twist, which
orients the C-terminal Thr83P down against the bottom of
the L- and R-domains. The structure confirms that the
mini-chain residue Cys80P is covalently linked to the R-
domain through a disulfide bridge to Cys205.
The active-site cleft in the region of the bound mini-chain
is narrower than those of other related structures. The
major narrowing feature on the right side is an insertion
loop of four residues (Lys155A, Thr155B, Pro155C and
Asp155D), while on the left side a part of the L-domain
consisting of residues Gln64–Gln70 comes closer (0.3 Å)
to the R-domain. In addition, the latter residues are pre-
ceded by a short insertion of two residues (Asn58A and
Phe58B) which extend the loop between Gln58 and
Asn59 into the active-site cleft. The narrowest place in the
cleft is between Leu67 and Pro155C, in the middle of
which is Cys205, which is involved in the disulfide bridge
with the mini-chain, completely closing the active-site
cleft. These three residues are involved in noncovalent
interactions and actually split the active-site cleft into two
parts (Figures 3 and 6).
In addition to the mini-chain, part of a carbohydrate chain
runs across the R- and L-domain interface. Three sugar
rings starting from Asn112 are unambiguously defined in
the electron-density map. Their structure is in agreement
with the nuclear magnetic resonance (NMR) observations
[40] that these are two N-acetylglucosamine residues
(NAG) and a mannose residue, linked by β(1–4) glycosidic
bonds. The rings shield a substantial part of surface of the
54 Structure 1998, Vol 6 No 1
Figure 3
Figure 4
Stereo view of the final |2|Fobs|–|Fcalc||
electron-density map of the cathepsin H
active site, contoured at 1.5σ (blue),
superimposed on a stick model of cathepsin
H. The main body of cathepsin H molecule is
shown in blue, the mini-chain in orange and
the symmetry-related molecule in pink. The
oxygen, nitrogen and sulfur atoms are
represented as small spheres in red, blue and
yellow, respectively. Water molecules are
drawn as pink spheres. The figure was
prepared with the program MAIN [61].
Stereo view of the mini-chain binding in the
active-site cleft. Amino acid residues
mentioned in text are marked. The structure is
color coded as in Figure 4. The N-terminal
Glu76P residue, which is undefined by
electron density, is drawn in green. Connolly
surface was calculated without the mini-chain.
The figure was prepared with the program
MAIN [61].
residues Val110, Glu73, Phe58B and Tyr77 from solvent.
The ring attached to Asn112 is involved in interactions
with the vicinal Pro77P of the mini-chain.
The mini-chain binds into the active-site cleft through the
sidechains of Gln78P, Cys80P and Thr83P (Figure 6). The
other sidechains point away from the bottom of the cleft
into the solvent. Their conformation is not as clearly
defined as the rest of the mini-chain structure and the posi-
tion and conformation of the N-terminal Glu76P residue is
not defined. No mainchain interactions with the underlying
enzyme surface, other than the C-terminal Thr83P and
Ser81P, are observed. However, a hydrogen bond is formed
between the peptide bond amide hydrogen atom of Gln78P
and the O6 atom of sugar residue NAG112A.
The hydrophobic wall formed by the sidechain contacts of
Leu67, disulfide bond Cys205–Cys80P and Pro155C splits
the active-site cleft underlying the mini-chain into two
parts. Each part contains a pocket. The surface of the front
pocket has primarily hydrophilic character, whereas the
surface of the back pocket is more hydrophobic (Figure 3).
The backside of the front pocket is formed by the side-
chains of Ser9 and Ser207 and a solvent molecule placed
beneath Leu67 and Cys205. On the right, there is the
glycosylated Asn112 residue, spanning with its carbohy-
drate moiety to the left, and on the right, there are several
carbonyl oxygen atoms and amide protons pointing into
the pocket. From the top right, Met115 extends its hydro-
phobic surface into the hydrophobic region of Pro155C
and Cys205. The amide group of the Gln78P sidechain is
anchored to the bottom of the front pocket, where it spans
between the Oγ atom of Ser69 and carbonyl group of
Ala206, thus contributing two additional hydrogen bonds
bridging the L- and R-domains. The rest of the pocket is
filled with three well-defined solvent molecules. The
strong binding of the Gln78P residue in the pocket is
demonstrated by its atomic temperature factors (18.0 Å2),
which are the lowest in the mini-chain.
The pocket behind Leu67 and the mini-chain disulfide is
the structural equivalent of the S2-binding site in other
cysteine proteases. In cathepsin H, this space is filled by
Thr83P. The sidechains of Ala133 and Val157 from the R-
domain provide the hydrophobic part of the surface,
against which the methyl group of the Thr83P sidechain
is packed. The carbonyl and amide groups of Gly66,
together with the aromatic ring of Trp26, provide a favor-
able environment for binding the amide and carboxyl
groups of Thr83P.
Discussion
The mini-chain defines the cathepsin H aminopeptidase
function
All papain-like cysteine proteases have the same basic
mechanism of action, but their specificity and point of
cleavage in the substrate differs from one member of the
family to another. The active-site cleft of cysteine endo-
peptidases like papain [38], actinidin [36], and cathepsins
L [33] and K [31,32] is unoccupied and so able to bind
substrates along its full length, whereas the active-site clefts
of cathepsins H and B, both exopeptidases, are partially
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Figure 5
Stereo view of the ||Fobs|–|Fcalc|| kicked omit
electron-density map of the mini-chain
contoured at 1.3σ (blue). Structure factors for
the kicked omit map were calculated from
randomly displaced atoms, up to 0.3 Å along
each coordinate. The mini-chain is shown in
orange sticks, the oligosaccharide moiety in
red, catalytic Cys25 and His159 in yellow and
all other residues, which are represented only
as a mainchain trace, in blue. The figure was
prepared with the program MAIN [61].
filled, thereby limiting the free substrate-binding sites. In
cathepsin B, a carboxydipeptidase, the active-site cleft
behind the S2′-binding site is occupied [34,41,42] and in
cathepsin H, an aminopeptidase, the active-site cleft in
front of the S1-binding site is blocked.
Cathepsin H utilizes a part of its propeptide, the mini-
chain, to partially fill the cleft and to provide a negatively
charged C-terminal carboxyl group of the mini-chain, which
presumably interacts with the positively charged N-terminal
amino group of a substrate P1 residue (Figure 7). The
mini-chain C-terminal residue Thr83P is located in, what
in the papain structure, is the S2-binding site.
The interatomic distance (peptide bond) between the P2
carbon atom and P1 nitrogen atom is at least 1.5 Å shorter
than the interatomic distance between the C-terminal
carbon atom of the mini-chain and the N-terminal nitrogen
atom of a P1 residue, which are involved in a non-covalent
interaction. Thus, it would appear that there could not be
sufficient space for a substrate to bind productively. This
difference is accommodated by the cathepsin H structure
as follows. The relative positioning of the central catalytic
residues (Cys25, His159 and Gln19) is preserved through-
out the structure of cathepsin H as compared with those of
actinidin [36], papain [39] and cathepsin B [34]. However,
in cathepsin H, the distance between the Cα atoms of the
56 Structure 1998, Vol 6 No 1
Figure 6
Schematic representation of the mini-chain
binding. The mini-chain (bold lines) is
covalently attached by the Cys80P–Cys205
disulfide bridge to the R-domain. Three other
residues of the mini-chain form hydrogen
bonds (dashed lines) and stabilize the mini-
chain position.
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Structure
catalytic residue Cys25 and Trp177 is shorter, whereas
there is more space between the Cα atom of Cys25 and the
Cα atoms of residues equivalent to those forming the S2
subsite in papain, actinidin and cathepsin B (Figure 8). The
shift in position of the scissile bond in the substrate may not
be sufficient to accommodate all the required increase of
interatomic distance. An additional source of accommoda-
tion to substrate might come from the mini-chain. The
mini-chain Thr83P residue is placed in a pocket much
larger then the residue itself, suggesting that when sub-
strate binds to cathepsin H, the Thr83P responds with a
shift towards the hydrophobic wall of Leu67 and the disul-
fide. This would allow substrate to bind further towards its
N-terminal direction, thus bringing the Cys25 thiol into line
with the scissile bond.
Interactions with substrate
In cathepsin H, there are no S3 or S2 substrate-binding
subsites, because the region equivalent to the related
endopeptidase subsites is occupied by the mini-chain
residues. The S1, S1′ and S2′ subsites are, however, free
and the positioning of the corresponding P1, P1′ and P2′
substrate residues can be predicted on the basis of the
related structures. Four substrate-binding subsites — S2,
S1, S1′ and S2′ — of the cysteine proteases were unam-
biguously identified with the help of the crystal structures
of substrate analogue chloromethyl-ketone inhibitors in
complex with papain [43] and the structure of the epoxy-
succinyl-based inhibitor (CA030) in complex with cathep-
sin B [44]. The fifth site, the S3 substrate-binding site, is
somewhat ambiguous, since the complexes between the
substrate analogue chloromethyl-ketone inhibitors and
papain and the structure of the stefin–papain complex [45]
indicate different binding possibilities. On this basis, the
substrate model for cathepsin B was generated [44] and
then transferred to the cathepsin H environment by super-
position of the protein structures. The P2 residue was
removed from the substrate model.
The substrate P1 residue can form an ionic interaction
with the mini-chain C-terminal carboxyl group. Its car-
bonyl occupies the oxyanion hole and the carbonyl of the
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Figure 7
Stereo view of the modeled substrate in the
active site. The structure of the body of
cathepsin H (blue sticks) is shown in the
Connolly surface (blue dots) with the predicted
substrate (green sticks) in the active site. The
mini-chain is represented as orange sticks and
was not included in Connolly surface
calculation. The catalytic residue His159 was
rotated about its Cα–Cβ bond to form an
active thiolate–imidazolium ion pair with Cys25.
The N terminus of the substrate is anchored to
the C-terminal carboxyl of Thr83P. Non-carbon
atoms are represented as small spheres, color
coded as in Figure 4. Possible hydrogen bonds
are drawn as dashed pink lines. The figure was
prepared with the program MAIN [61].
Figure 8
Stereo view of the superimposed structures of
cathepsin H (thick lines), cathepsin B
(medium lines) and papain (thin lines) showing
the displacement of the residues in the active-
site cleft of cathepsin H. Disulfide bridges are
shown as dashed lines. Cathepsin B (1huc)
and papain (9pap) structures were
superimposed on cathepsin H, minimizing rms
deviations of topologically equivalent Cα
atoms.
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P1′ residue forms a hydrogen bond with the hydrogen of
the Trp177 Nε atom (Figure 7). The sidechain interac-
tions can, however, not be predicted as exactly as the
mainchain interactions because of lack of structural data,
but their binding sites on the cathepsin H surface can be
clearly located, allowing us to discuss their specificity.
Cathepsin H shows a preference for residues with large
hydrophobic (Phe, Trp, Leu and Tyr) or basic (Arg and
Lys) sidechains at the P1 position over residues containing
small or polar sidechains [26]. The predicted substrate
model shows that the P1 residue sidechain points along
the wall of the active-site cleft towards the solvent region.
There are no special groups on the surface of the S1
subsite that favor a particular type of residue, so the larger
amino-acid sidechains at the P1 position presumably bind
more strongly, owing to their more extensive contact
surface with the wall of the enzyme.
The S1′ subsite is, like that of the other enzymes in the
family, expected to be more specific, because the sidechain
of a P1′ substrate residue can form a relatively large contact
surface within a pocket. No experimental data for the speci-
ficity of this site, however, are known to us. The residues
Val136, Leu142 and Phe141 form the walls of the pocket.
These residues are identical in composition and conforma-
tion to those of cathepsin B, suggesting that binding of
isoleucine and leucine may be preferred, as in the case of
cathepsin B. There is, however, no equivalent residue to
Met196 in cathepsin B, which encloses the hydrophobic
surface of that S1′ subsite from the top. However, Asn158
and Val157, preceding His159, are placed similarly to the
equivalent residues in the endopeptidase structures. The
chain preceding these residues, including a short four-
residue insertion, follows a unique route before it merges
at the position of Tyr149 into the path of the chain of the
other related structures. This part actually narrows the
active-site cleft and thereby helps to stabilize the position-
ing of the mini-chain residues within the cleft. The pre-
dicted S2′ subsite of cathepsin H is quite broad and exposed
to solvent. The structure reveals no particular feature, and
we may assume that hydrophilic and aromatic residues, due
to exposure of the site to solvent, would be preferred.
In the light of recent work [46], the unusual positioning of
the His159 imidazole ring may not be as unusual as it
appears. Negative charges from the top or bottom of the
enzyme may provide an electrostatic switch between the
active form of a cysteine protease, in which the thiolate–
imidazole pair is formed, and an inactive form in which
the positively charged histidine imidazole ring is exposed
to solvent. 
Interactions with cysteine protease inhibitors
The crystal structures of complexes of the inhibitor E-64
with actinidin [47], papain [48] and cathepsin L [33] have
shown that E-64 binds into the S1, S2 and S3 substrate-
binding sites of the proteases. If it were to bind in the
same way to cathepsin H, it is evident that it would
compete with the mini-chain residues for the same binding
sites. This could be the reason for the slow binding of
E-64 to cathepsin H compared to other related enzymes
[21]. For the same reason, leupeptin [24] and diazo-
methane dipeptides [25] do not bind to the enzyme.
Modeling of complexes between stefins and cathepsin H
(models not shown), based on the stefin B–papain complex
[45], raises questions about the structure of these com-
plexes. According to the models, both hairpin loops of
human stefin B fit well into the active-site cleft of cathep-
sin H, but the N-terminal trunk of stefin B collides with
the mini-chain residues, in particular with the Thr83P. 
Processing
The sequence of preprocathepsin H was obtained from
the cDNA sequence. In vivo, the prepeptide is cleaved co-
translationally, and the proenzyme is processed post-trans-
lationally during lysosome maturation [49].
As seen from the amino acid sequence and the structure,
maturation of cathepsin H includes at least three cleav-
ages of the proenzyme chain: at the enzyme N terminus
and at both termini of the mini-chain. During processing,
a ten-residue peptide, connecting the mini-chain with the
N-terminal residue of the enzyme Tyr1 and the propep-
tide chain preceding the mini-chain, is removed.
Structures of related zymogens of procathepsin B [42,50,
51], procathepsin L [52] and procaricain [53] have revealed
that the propeptide of a cysteine protease binds along the
active-site cleft in the direction opposite to that of the
bound substrate. The mini-chain, however, as part of the
cathepsin H propeptide, binds in the mature enzyme
along the active-site cleft in the substrate-binding direc-
tion. The question here is whether the positioning of the
mini-chain observed in the mature enzyme is present also
in the zymogen form. Assuming that the zymogen is a
form designed in order to allow controlled activation of the
enzyme, the cathepsin H propeptide should not bind
along the active-site cleft in the substrate-binding direc-
tion, otherwise it would be cleaved. This means that the
mini-chain would be positioned differently in the zymogen
from the mature enzyme. 
On this basis, we suggest that the processing of procathep-
sin H occurs in at least three steps, in which the molecule
is transformed from its zymogen form, via an enzymati-
cally active intermediate exhibiting endopeptidase activ-
ity, into an aminopeptidase. In the first step, a cleavage
liberates the mini-chain N terminus from the main body
of the propeptide chain. The cleavage site is probably at
the mini-chain N-terminal residue Glu76P. In the second,
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step a peptide bond close to the mature enzyme N termi-
nus is cleaved. The mini-chain remains attached to the
body of the molecule only by means of the disulfide bond.
In the third step, the mini-chain reorients and positions
along the active-site cleft in the direction of a bound sub-
strate and gets processed to its eventual C terminus
(Thr83P) by the catalytic site of the same molecule. After
this cleavage, the mini-chain pulls back and adopts the
observed conformation and thus turns the enzyme into an
aminopeptidase. The N terminus of the enzyme is addi-
tionally processed to its final sequence. 
Biological implications
Papain-like cysteine proteases are important enzymes
involved in intracellular protein turnover. They can also
degrade extracellular matrix components, for which
reason they are associated with numerous pathological
conditions. All of these enzymes have the same basic
mechanism of action, but their specificity and point of
cleavage in the substrate differs from one member of the
family to another. Endopeptidases cleave proteins to
large fragments and exopeptidases, like cathepsin H,
digest those fragments to single amino acids. 
Cathepsin H is a lysosomal proteolytic enzyme, special-
ized to remove the N-terminal residue from proteins and
peptides. Its sequence shows it to belong to the papain
family of enzymes, with which it shares a common three-
dimensional structure, with a thiol group as one of the
catalytic residues. It is synthesized as an inactive proen-
zyme from which it is activated by controlled proteolysis.
The X-ray structure described here confirms that the
overall structure is similar to that of other cysteine pro-
teases, but it shows how the basic endopeptidase structure
is modified to achieve the aminopeptidase activity.
It has previously been shown that, on activation, a small
portion of the pro-region — the mini-chain — remains
bound to the enzyme through a disulfide bond. The
structure of the enzyme described here shows that this
mini-chain is bound in one end of the active-site cleft,
thus limiting the size of substrate that can be bound and
cleaved. There is room for only one residue to be bound
on the N-terminal side of the catalytic site. Other minor
structural changes are seen that fine tune the location of
the substrate, so that the peptide bond joining the N-ter-
minal residue to the rest of the protein is located pre-
cisely over the thiol group. The mini-chain also performs
another role in substrate binding. Its position and orien-
tation are such that its negatively charged terminal car-
boxyl group points into the cleft, where it can interact
with the N-terminal amino group of the substrate. 
This structure provides an informative example of
economy in evolution. It shows how one type of 3D
structure has been modified to produce a different kind
of proteolytic activity, rather than resorting to a basi-
cally different structure. The modification also involves
the use of the pre-existing pro-peptide which evolved
originally for the different purpose of controlled switch-
ing of the proteolytic activity.
Materials and methods
Isolation 
Cathepsin H was isolated from porcine spleen. The purification proce-
dure was based on the method described by Popovic et al. [9]. The
purity and identity of cathepsin H was checked by SDS–PAGE and N-
terminal amino-acid sequence analysis. The purified protein was con-
centrated in a spin concentrator (Centricon (Amicon)) to a concentration
of 11 mg/ml. N-terminal analysis of the reduced enzyme showed three
sequences that correspond to heavy, light and mini-chain. Cathepsin H
was isolated in two- and three-chain forms. Both forms contain the
eight-residue long mini-chain. The three-chain form has N-terminal
heavy and C-terminal light chains, consisting of 177 and 43 amino acid
residues respectively.
Primary structure determination (cDNA cloning)
Total RNA was isolated from the buffy coat obtained from fresh heparin-
treated porcine peripheral blood by homogenization in guanidinium thio-
cyanate [54] and centrifugation in a solution of cesium trifluoroacetate
[55]. Poly(A)+ RNA was purified on oligo(dT)-cellulose and cDNA syn-
thesized using an Amersham cDNA synthesis system. EcoRI–XhoI
adapters (Stratagene) were ligated to the cDNA and a cDNA library was
constructed in λgt11 using a kit (Amersham). A 939 bp fragment of
human procathepsin H cDNA (prepared by polymerase chain reaction
(PCR) from human placental cDNA using primers corresponding to the
sequence reported by Fuchs et al. [56]) was labeled by [35S]dATPαS
(Amersham) using Random Primed DNA Labeling Kit (Boehringer). A
portion of the cDNA library of about 105 plaque-forming units was spread
on LBA plates and blotted to Hybond-N membranes (Amersham). The
membranes were hybridized with a 35S-labeled human procathepsin H
fragment according to Sambrook et al. [57]. A single positive plaque
was picked and subjected to two rounds of purification. From the posi-
tive clone, λ DNA was isolated, digested with EcoRI and both the result-
ing fragments, of about 1.15 kb and 1 kb, inserted into pUC19. The
1.15 kb fragment, which comprised the entire coding sequence of
porcine preprocathepsin H and 115 bp of the 3’ untranslated region,
was completely sequenced on both strands using a T7 sequencing kit
(Pharmacia). The cDNA sequence of porcine preprocathepsin H cDNA
reported here has been submitted to the DDBJ/EMBL/GenBank data-
bases under accession number AF001169.
Crystallization, X-ray data collection and structure
determination
Crystals were grown by the sitting drop vapor diffusion method. The
reservoir contained 1 ml 0.05 M sodium acetate and 5% mme-PEG 5K
buffer pH 4.8. The drop was composed of 2 µl reservoir solution and
2 µl cathepsin H in 20 mM sodium acetate and 1 mM EDTA buffer
pH 5.0. Concentration of applied protein was 11 mg/ml.
Diffraction data were collected from a single crystal using Cu Kα radia-
tion from a Rigaku rotating anode X-ray generator and recorded on
18 cm MAR Research image plate detector. Auto indexing and scaling
was done using HKL programs [58]. The crystal diffracted beyond
1.98 Å resolution and belonged to the orthorhombic space group
P212121 with cell dimensions a = 38.4 Å, b = 68.7 Å, c = 86.8 Å. It
contained one molecule in the asymmetric unit. Orientation and transla-
tion of the cathepsin H molecule were determined using a molecular
replacement method implemented in AMoRe program [59]. The crystal
structures of papain [39], actinidin [36], papaya proteinase omega [60]
and cathepsin B [34] together and separately were used as a search
model. A set of consistent solutions was found, the actinidin structure
giving the best result, with a correlation factor of 0.29 and R value of
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0.51 using data in the 15 Å to 4.0 Å resolution range. The crystal pack-
aging was inspected on a graphical display using MAIN [61]. The first
density maps were calculated using the actinidin structure and reflec-
tion data between 15 Å and 3.5 Å resolution. The subsequent interac-
tive sessions using MAIN included model building, crystallographic
refinement and structure analysis. The data resolution was gradually
expanded to the final range (8.0 Å–2.1 Å). Refinement also included
simulated annealing and conjugate gradient minimization procedures in
X-PLOR [62]. Standard parameters for protein [63] and carbohydrate
[64] parameters, as provided by X-PLOR, were used for geometry reg-
ularization. Kicked omit maps were used throughout the structure
determination process to reveal ambiguous parts of the structure.
Structure factors for the kicked omit maps were calculated from ran-
domly displaced atoms, up to 0.3 Å along each coordinate. Water mol-
ecules were generated using an automatic procedure in MAIN and
then corrected manually in several steps during refinement. After the
crystallographic R value dropped to 0.25 at 2.1 Å resolution, the tem-
perature factor refinement was applied. The mini-chain was built into a
kicked omit map. The mini-chain direction was additionally verified
using an Rfree criterion: the R value for the structure with the mini-chain
oriented in the correct direction was 0.236 and the Rfree value 0.267,
while the values for the structure with the mini-chain running in the
opposite direction were 0.251 and 0.316, respectively. The final refine-
ment included all reflections and yielded the final model at 2.1 Å resolu-
tion, with the crystallographic R value being 0.198 and the Rfree value
for 10% of the reflections, 0.245. The geometry of the final model was
inspected with MAIN and PROCHECK [65]. All residues lie in the
allowed regions of the Ramachandran plot, 84.3% of residues in most
favored regions and 15.7% in additional allowed regions. Other struc-
tural parameters for the structure refined at this resolution show no sig-
nificant deviations from the expected values (overall G factor is 0.2
which is better than expected for 2.1 Å resolution). The crystallographic
data and refinement statistics are summarized in Table 1. 
Accession numbers
The coordinates have been deposited in the Brookhaven Protein Data
Bank with accession code 8pch.
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